11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus
出版年份 2012 全文链接
标题
11β-Hydroxysteroid dehydrogenase type 1: relevance of its modulation in the pathophysiology of obesity, the metabolic syndrome and type 2 diabetes mellitus
作者
关键词
-
出版物
DIABETES OBESITY & METABOLISM
Volume 14, Issue 10, Pages 869-881
出版商
Wiley
发表日期
2012-02-10
DOI
10.1111/j.1463-1326.2012.01582.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
- (2011) Stéphane Quideau et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Upregulation of Hepatic 11β-Hydroxysteroid Dehydrogenase-1 Expression in Calcium-Deficient Rats
- (2011) Junji Takaya et al. ANNALS OF NUTRITION AND METABOLISM
- Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone (KR-66344)
- (2011) Ji Seon Park et al. BIOCHEMICAL PHARMACOLOGY
- Generation of 3,8-substituted 1,2,4-triazolopyridines as potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1)
- (2011) Haixia Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Increased Whole-Body and Sustained Liver Cortisol Regeneration by 11β-Hydroxysteroid Dehydrogenase Type 1 in Obese Men With Type 2 Diabetes Provides a Target for Enzyme Inhibition
- (2011) Roland H. Stimson et al. DIABETES
- Current therapeutic strategies in non-alcoholic fatty liver disease
- (2011) J. K. Dowman et al. DIABETES OBESITY & METABOLISM
- Effects of an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, MK-0916, in patients with type 2 diabetes mellitus and metabolic syndrome
- (2011) P. U. Feig et al. DIABETES OBESITY & METABOLISM
- Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity
- (2011) Juan Liu et al. ENDOCRINE JOURNAL
- Magnesium deficiency in pregnant rats alters methylation of specific cytosines in the hepatichydroxysteroid dehydrogenase-2promoter of the offspring
- (2011) Junji Takaya et al. Epigenetics
- Carbenoxolone Alters the Morphology of Adipose Tissues and Downregulates Genes Involved in Adipogenesis, Glucose Transport and Lipid Metabolism in High-Fat Diet-fed Mice
- (2011) S. Sano et al. HORMONE AND METABOLIC RESEARCH
- Synthesis of Potent and Orally Efficacious 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor HSD-016
- (2011) Zhao-Kui Wan et al. JOURNAL OF ORGANIC CHEMISTRY
- Momordica charantia extract, a herbal remedy for type 2 diabetes, contains a specific 11β-hydroxysteroid dehydrogenase type 1 inhibitor
- (2011) Andreas Blum et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Efficacy and safety of the selective 11β-HSD-1 inhibitors MK-0736 and MK-0916 in overweight and obese patients with hypertension
- (2011) Sukrut Shah et al. Journal of the American Society of Hypertension
- Flavonoids Health Benefits and Their Molecular Mechanism
- (2011) Z.-P. Xiao et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: Possible contribution of 11β-hydroxysteroid dehydrogenase type 1 inhibition in rodent adipose tissue
- (2011) Noriko Tagawa et al. STEROIDS
- Azabicyclic sulfonamides as potent 11β-HSD1 inhibitors
- (2010) Unmesh Shah et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Modulation of 11β-hydroxysteroid dehydrogenase type 1 activity by 1,5-substituted 1H-tetrazoles
- (2010) Scott P. Webster et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Emodin, a natural product, selectively inhibits 11β-hydroxysteroid dehydrogenase type 1 and ameliorates metabolic disorder in diet-induced obese mice
- (2010) Ying Feng et al. BRITISH JOURNAL OF PHARMACOLOGY
- 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors as Promising Therapeutic Drugs for Diabetes: Status and Development
- (2010) R. Ge et al. CURRENT MEDICINAL CHEMISTRY
- The 11- -Hydroxysteroid Dehydrogenase Type 1 Inhibitor INCB13739 Improves Hyperglycemia in Patients With Type 2 Diabetes Inadequately Controlled by Metformin Monotherapy
- (2010) J. Rosenstock et al. DIABETES CARE
- 11β-Hydroxysteroid dehydrogenase type 1 inhibition in type 2 diabetes mellitus
- (2010) G. Hollis et al. DIABETES OBESITY & METABOLISM
- Differences in associations between HSD11B1 gene expression and metabolic parameters in subjects with and without impaired glucose homeostasis
- (2010) C. Karlsson et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Obesity Affects the Liver – The Link between Adipocytes and Hepatocytes
- (2010) Alexander Wree et al. DIGESTION
- A comparative study of flavonoid analogues on streptozotocin–nicotinamide induced diabetic rats: Quercetin as a potential antidiabetic agent acting via 11β-Hydroxysteroid dehydrogenase type 1 inhibition
- (2010) Mariana Torres-Piedra et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- 11β-Hydroxysteroid dehydrogenase type 1 inhibitors for the treatment of type 2 diabetes
- (2010) Stuart A Morgan et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- In Vivo Activity of 11β-Hydroxysteroid Dehydrogenase Type 1 in Man: Effects of Prednisolone and Chenodesoxycholic Acid
- (2010) S. Diederich et al. HORMONE AND METABOLIC RESEARCH
- Weight Loss after Gastric Bypass Surgery in Women Is Followed by a Metabolically Favorable Decrease in 11β-Hydroxysteroid Dehydrogenase 1 Expression in Subcutaneous Adipose Tissue
- (2010) Kotryna Šimonytė et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The metabolic syndrome: time to get off the merry-go-round?
- (2010) G. M. Reaven JOURNAL OF INTERNAL MEDICINE
- Discovery of a Potent, Orally Active 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitor for Clinical Study: Identification of (S)-2-((1S,2S,4R)-Bicyclo[2.2.1]heptan-2-ylamino)-5-isopropyl-5-methylthiazol-4(5H)-one (AMG 221)
- (2010) Murielle M. Véniant et al. JOURNAL OF MEDICINAL CHEMISTRY
- The glucocorticoid-activating enzyme 11β-hydroxysteroid dehydrogenase type 1 has broad substrate specificity: Physiological and toxicological considerations
- (2010) Alex Odermatt et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- 11β-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation
- (2010) Claudia A. Staab et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Targeting the pre-receptor metabolism of cortisol as a novel therapy in obesity and diabetes
- (2010) Laura L. Gathercole et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Dietary fatty acid composition alters 11β-hydroxysteroid dehydrogenase type 1 gene expression in rat retroperitoneal white adipose tissue
- (2010) Sakamuri SS Vara Prasad et al. Lipids in Health and Disease
- Fructose and metabolic diseases: New findings, new questions
- (2010) Luc Tappy et al. NUTRITION
- High Fructose Diets Increase 11β-Hydroxysteroid Dehydrogenase Type 1 in Liver and Visceral Adipose in Rats Within 24-h Exposure
- (2010) Edra London et al. Obesity
- Associations of Visceral and Liver Fat With the Metabolic Syndrome Across the Spectrum of Obesity: The AGES–Reykjavik Study
- (2010) Lauren J. Kim et al. Obesity
- Metabolic Effects of Fructose and the Worldwide Increase in Obesity
- (2010) Luc Tappy et al. PHYSIOLOGICAL REVIEWS
- The influence of beverage composition on delivery of phenolic compounds from coffee and tea
- (2010) Mario G. Ferruzzi PHYSIOLOGY & BEHAVIOR
- Cell-based assay for screening 11β-hydroxysteroid dehydrogenase 1 inhibitors
- (2009) Young Sik Cho et al. ANALYTICAL BIOCHEMISTRY
- The role of 11β-hydroxysteroid dehydrogenase type 2 in human hypertension
- (2009) Paolo Ferrari BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Discovery of novel dual functional agent as PPARγ agonist and 11β-HSD1 inhibitor for the treatment of diabetes
- (2009) Yang-liang Ye et al. BIOORGANIC & MEDICINAL CHEMISTRY
- N-(Pyridin-2-yl) arylsulfonamide inhibitors of 11β-hydroxysteroid dehydrogenase type 1: Discovery of PF-915275
- (2009) Michael Siu et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- 4-(Phenylsulfonamidomethyl)benzamides as potent and selective inhibitors of the 11β-hydroxysteroid dehydrogenase type 1 with efficacy in diabetic ob/ob mice
- (2009) Xu Zhang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Harmonizing the Metabolic Syndrome
- (2009) K.G.M.M. Alberti et al. CIRCULATION
- Hypothalamic-Pituitary-Adrenal (HPA) axis functioning in relation to body fat distribution
- (2009) Femke Rutters et al. CLINICAL ENDOCRINOLOGY
- 11 -Hydroxysteroid Dehydrogenase Type 1 Regulates Glucocorticoid-Induced Insulin Resistance in Skeletal Muscle
- (2009) S. A. Morgan et al. DIABETES
- Antidiabetic effects of 11β-HSD1 inhibition in a mouse model of combined diabetes, dyslipidaemia and atherosclerosis
- (2009) D. J. Lloyd et al. DIABETES OBESITY & METABOLISM
- Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?
- (2009) D. H. van Raalte et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- 11β-Hydroxysteroid Dehydrogenase Type 1 and Its Role in the Hypothalamus-Pituitary-Adrenal Axis, Metabolic Syndrome, and Inflammation
- (2009) Mark S. Cooper et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis
- (2009) Panagiotis Anagnostis et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans
- (2009) Kimber L. Stanhope et al. JOURNAL OF CLINICAL INVESTIGATION
- Efficacious 11β-Hydroxysteroid Dehydrogenase Type I Inhibitors in the Diet-Induced Obesity Mouse Model
- (2009) Zhao-Kui Wan et al. JOURNAL OF MEDICINAL CHEMISTRY
- Diet and the role of 11β-hydroxysteroid dehydrogenase-1 on obesity
- (2009) Edra London et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Selective inhibition of 11β-hydroxysteroid dehydrogenase 1 by 18α-glycyrrhetinic acid but not 18β-glycyrrhetinic acid
- (2009) Dirk Classen-Houben et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Calcium intake is inversely associated with metabolic syndrome in postmenopausal women
- (2009) Geum Joon Cho et al. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY
- Obesity and corticosteroids: 11β-Hydroxysteroid type 1 as a cause and therapeutic target in metabolic disease
- (2009) Nicholas Michael Morton MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Regulation of the Hypothalamic-Pituitary-Adrenal Axis
- (2009) Anastasios Papadimitriou et al. NEUROIMMUNOMODULATION
- Obesity Is Accompanied by Disturbances in Peripheral Glucocorticoid Metabolism and Changes in FA Recycling
- (2009) Kotryna Simonyte et al. Obesity
- Overexpression of 11β-Hydroxysteroid Dehydrogenase Type 1 in Hepatic and Visceral Adipose Tissue is Associated with Metabolic Disorders in Morbidly Obese Patients
- (2009) René Baudrand et al. OBESITY SURGERY
- Effects of bile acids on rat hepatic microsomal type I 11β-hydroxysteroid dehydrogenase
- (2009) Yorio Maeda et al. STEROIDS
- Lower growth hormone and higher cortisol are associated with greater visceral adiposity, intramyocellular lipids, and insulin resistance in overweight girls
- (2008) Madhusmita Misra et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Direct protein–protein interaction of 11β-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the endoplasmic reticulum lumen
- (2008) Atanas G. Atanasov et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Sub-chronic administration of the 11β-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity
- (2008) Ashley Taylor et al. BIOLOGICAL CHEMISTRY
- Distinctive molecular inhibition mechanisms for selective inhibitors of human 11β-hydroxysteroid dehydrogenase type 1
- (2008) Hua Tu et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Selective Inhibitors of 11 -Hydroxysteroid Dehydrogenase Type 1 for Patients With Metabolic Syndrome: Is the Target Liver, Fat, or Both?
- (2008) P. M. Stewart et al. DIABETES
- Impaired Glucose Tolerance and Insulin Resistance Are Associated With Increased Adipose 11 -Hydroxysteroid Dehydrogenase Type 1 Expression and Elevated Hepatic 5 -Reductase Activity
- (2008) J. W. Tomlinson et al. DIABETES
- Natural products in drug discovery
- (2008) A HARVEY DRUG DISCOVERY TODAY
- 7-Oxysterols Modulate Glucocorticoid Activity in Adipocytes through Competition for 11β-Hydroxysteroid Dehydrogenase Type
- (2008) Malgorzata Wamil et al. ENDOCRINOLOGY
- 11-Beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors in Type 2 diabetes mellitus and obesity
- (2008) Katherine A Hughes et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Association between the Metabolic Syndrome and Serum Cortisol in Overweight Latino Youth
- (2008) Marc J. Weigensberg et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- A novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor prevents human adipogenesis
- (2008) I J Bujalska et al. JOURNAL OF ENDOCRINOLOGY
- Fructose consumption as a risk factor for non-alcoholic fatty liver disease
- (2008) Xiaosen Ouyang et al. JOURNAL OF HEPATOLOGY
- Discovery of Novel, Potent Benzamide Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1) Exhibiting Oral Activity in an Enzyme Inhibition ex Vivo Model▽
- (2008) Lisa D. Julian et al. JOURNAL OF MEDICINAL CHEMISTRY
- 2-Amino-1,3-thiazol-4(5H)-ones as Potent and Selective 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors: Enzyme−Ligand Co-Crystal Structure and Demonstration of Pharmacodynamic Effects in C57Bl/6 Mice
- (2008) Lars Johansson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Development of 11β -HSD1 Inhibitors for the Treatment of Type 2 Diabetes
- (2008) Clarence Hale et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Hexose-6-phosphate dehydrogenase modulates the effect of inhibitors and alternative substrates of 11β-hydroxysteroid dehydrogenase 1
- (2008) Zoltán Balázs et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- 11β-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP+ and is stimulated by extracellular glucose
- (2008) Anna A. Dzyakanchuk et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- 11β-Hydroxysteroid Dehydrogenase Type 1 is Overexpressed in Subcutaneous Adipose Tissue of Morbidly Obese Patients
- (2008) Rodrigo Muñoz et al. OBESITY SURGERY
- Inhibition of 11βHSD1 with the S-phenylethylaminothiazolone BVT116429 increases adiponectin concentrations and improves glucose homeostasis in diabetic KKAy mice
- (2008) Maj Sundbom et al. BMC Pharmacology & Toxicology
- Modulation of 11β-Hydroxysteroid Dehydrogenase (11βHSD) Activity Biomarkers and Pharmacokinetics of PF-00915275, a Selective 11βHSD1 Inhibitor
- (2007) Rachel Courtney et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now